Héroux-Devtek Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Héroux-Devtek ha aumentado sus beneficios a una tasa media anual de 13.4%, mientras que los beneficios de la industria de Aerospace & Defense han experimentado un crecimiento de 5.7% anual. Los ingresos han ido creciendo a una tasa media de 0.9% al año. La rentabilidad financiera de Héroux-Devtek es de 5.9%, y sus márgenes netos son de 4%.

Información clave

13.4%

Tasa de crecimiento de los beneficios

14.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Aerospace & Defense	-2.0%
Tasa de crecimiento de los ingresos	0.9%
Rentabilidad financiera	5.9%
Margen neto	4.0%
Próxima actualización de resultados	22 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 10

Results: Héroux-Devtek Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 18

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Héroux-Devtek. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

TSX:HRX Ingresos, gastos y beneficios (CAD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	602	24	52
30 Sep 23	579	17	53
30 Jun 23	570	17	50
31 Mar 23	544	14	48
31 Dec 22	535	19	48
30 Sep 22	525	24	45
30 Jun 22	524	27	44
31 Mar 22	536	33	44
31 Dec 21	544	30	43
30 Sep 21	563	32	47
30 Jun 21	569	28	48
31 Mar 21	571	20	50
31 Dec 20	582	-61	51
30 Sep 20	589	-61	50
30 Jun 20	598	-58	51
31 Mar 20	613	-50	51
31 Dec 19	604	34	52
30 Sep 19	591	33	50
30 Jun 19	542	29	47
31 Mar 19	484	26	42
31 Dec 18	439	20	37
30 Sep 18	391	13	34
30 Jun 18	385	13	32
31 Mar 18	387	14	31
31 Dec 17	394	17	32
30 Sep 17	396	24	32
30 Jun 17	398	31	34
31 Mar 17	407	32	35
31 Dec 16	403	32	35
30 Sep 16	401	31	35
30 Jun 16	404	27	35
31 Mar 16	407	27	35
31 Dec 15	395	16	34
30 Sep 15	387	7	34
30 Jun 15	377	4	33
31 Mar 15	365	3	32
31 Dec 14	350	6	31
30 Sep 14	323	11	27
30 Jun 14	295	10	24
31 Mar 14	272	9	21
31 Dec 13	255	13	20
30 Sep 13	255	13	20
30 Jun 13	256	13	20

Ingresos de calidad: HRX tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (4%) de HRX son superiores a los del año pasado (3.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de HRX han crecido un 13.4% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de HRX en el último año (25.6%) supera su media de 5 años (13.4% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de HRX en el último año (25.6%) superó al de la industria Aerospace & Defense 18%.

Héroux-Devtek Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Información clave

Actualizaciones de resultados anteriores recientes

Héroux-Devtek Inc. to Report Q4, 2024 Results on May 22, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Héroux-Devtek Inc. to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Héroux-Devtek Inc. to Report Q2, 2024 Results on Nov 10, 2023

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Recent updates

Héroux-Devtek Inc. to Report Q4, 2024 Results on May 22, 2024

Price target increased by 7.5% to CA$24.50

Results: Héroux-Devtek Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is Now The Time To Look At Buying Héroux-Devtek Inc. (TSE:HRX)?

Consensus EPS estimates increase by 26%

Price target increased by 7.3% to CA$20.70

Héroux-Devtek Inc. to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Héroux-Devtek Inc. to Report Q2, 2024 Results on Nov 10, 2023

New major risk - Financial position

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 20% undervalued

Héroux-Devtek Inc., Annual General Meeting, Aug 08, 2023

Now 20% undervalued

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 40%

Third quarter 2023 earnings: Revenues in line with analyst expectations

Consensus EPS estimates fall by 42%

At CA$16.20, Is Héroux-Devtek Inc. (TSE:HRX) Worth Looking At Closely?

Investor sentiment improves as stock rises 16%

Héroux-Devtek Inc. to Report Q3, 2023 Results on Feb 08, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Héroux-Devtek Inc. to Report Q2, 2023 Results on Nov 11, 2022

Consensus EPS estimates fall by 28%

Price target decreased to CA$21.80

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Héroux-Devtek Inc. to Report Q1, 2023 Results on Aug 05, 2022

Insider exercised options to buy CA$74k worth of stock.

CFO & VP recently sold CA$383k worth of stock

Héroux-Devtek Inc., Annual General Meeting, Aug 05, 2022

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 13%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Now 23% undervalued after recent price drop

President exercised options to buy CA$568k worth of stock.

Second quarter 2022 earnings released: EPS CA$0.21 (vs CA$0.11 in 2Q 2021)

Executive Chairman of the Board exercised options to buy CA$325k worth of stock.

First quarter 2022 earnings released: EPS CA$0.19 (vs CA$0.038 loss in 1Q 2021)

President exercised options to buy CA$188k worth of stock.

Is It Time To Consider Buying Héroux-Devtek Inc. (TSE:HRX)?

We Like Héroux-Devtek's (TSE:HRX) Earnings For More Than Just Statutory Profit

Full year 2021 earnings released: EPS CA$0.55 (vs CA$1.38 loss in FY 2020)

Price target increased to CA$22.00

Calculating The Fair Value Of Héroux-Devtek Inc. (TSE:HRX)

Is Héroux-Devtek (TSE:HRX) Using Too Much Debt?

New 90-day high: CA$16.46

Our Take On The Returns On Capital At Héroux-Devtek (TSE:HRX)

This Insider Has Just Sold Shares In Héroux-Devtek Inc. (TSE:HRX)

Héroux-Devtek Inc. Appoints Didier Evrard as Director

Third quarter 2021 earnings released: EPS CA$0.24 (vs CA$0.24 in 3Q 2020)

Revenue and earnings beat expectations

Price target raised to CA$18.83

New 90-day high: CA$15.40

Is There Now An Opportunity In Héroux-Devtek Inc. (TSE:HRX)?

A Look At The Intrinsic Value Of Héroux-Devtek Inc. (TSE:HRX)

Héroux-Devtek Inc. to Report Q3, 2021 Results on Feb 05, 2021

New 90-day high: CA$14.94

A Look At Héroux-Devtek's (TSE:HRX) Share Price Returns

What You Need To Know About Héroux-Devtek Inc.'s (TSE:HRX) Investor Composition

How Much Are Héroux-Devtek Inc. (TSE:HRX) Insiders Spending On Buying Shares?

Results: Héroux-Devtek Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Price target raised to CA$16.33

Revenue and earnings beat expectations

New 90-day high: CA$12.29

Héroux-Devtek Inc. to Report Q2, 2021 Results on Nov 13, 2020

Héroux-Devtek Inc.'s CESA subsidiary in Spain Receives Major Multi-Year Supply Agreement with Boeing for the Manufacture of Several Actuation Components

New 90-day low: CA$9.24

Desglose de ingresos y gastos
Beta